We are live on
!
Find out more
New York State Common Retirement Fund Portfolio holdings
AUM
$79.3B
1-Year Est. Return
43.63%
This Fund
S&P 500
This Quarter
Est. Return
+9.95%
1 Year Est. Return
+43.63%
3 Year Est. Return
+132.82%
5 Year Est. Return
+173.87%
10 Year Est. Return
+697.67%
AUM
$84.1B
AUM Growth
+$5.09B
(+6.4%)
Cap. Flow
-$1.63B
Cap. Flow
% of AUM
-1.94%
Top 10 Holdings %
Top 10 Hldgs %
18.93%
Holding
3,277
New
52
Increased
520
Reduced
1,986
Closed
73
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$86.8M |
| 2 |
Alibaba
BABA
|
+$75.7M |
| 3 |
Truist Financial
TFC
|
+$58M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$46.8M |
| 5 |
Baxter International
BAX
|
+$44.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$159M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$56.2M |
| 3 |
Apple
AAPL
|
+$55.2M |
| 4 |
Deere & Co
DE
|
+$54.1M |
| 5 |
JPMorgan Chase
JPM
|
+$48.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.32% |
| 2 | Financials | 15.73% |
| 3 | Healthcare | 14.42% |
| 4 | Consumer Discretionary | 10.02% |
| 5 | Communication Services | 9.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TVRD
2126
Tvardi Therapeutics
TVRD
$22M
| $619K | ﹤0.01% |
1,067
-2
| -0.2% | -$1.4K |
|
2127
Intellia Therapeutics
NTLA
$1.68B
| $618K | ﹤0.01% |
42,140
| – | – |
|
2128
Astronics
ATRO
$3.72B
| $615K | ﹤0.01% |
26,400
-4,440
| -14% | -$109K |
|
2129
America's Car Mart
CRMT
$26.1M
| $614K | ﹤0.01% |
5,600
-1,000
| -15% | -$96.8K |
|
2130
Akebia Therapeutics
AKBA
$234M
| $612K | ﹤0.01% |
96,902
-24,200
| -20% | -$115K |
|
|
AAMI
2131
Acadian Asset Management
AAMI
$3.22B
| $611K | ﹤0.01% |
59,800
-10,000
| -14% | -$97.6K |
|
|
FBMS
2132
DELISTED
The First Bancshares, Inc.
FBMS
| $611K | ﹤0.01% |
17,200
| – | – |
|
2133
Village Super Market
VLGEA
$616M
| $609K | ﹤0.01% |
26,233
-850
| -3% | -$22K |
|
|
VRS
2134
DELISTED
Verso Corporation
VRS
| $609K | ﹤0.01% |
33,800
-25,575
| -43% | -$410K |
|
2135
Manitowoc
MTW
$678M
| $606K | ﹤0.01% |
34,650
| – | – |
|
2136
Horizon Bancorp
HBNC
$1.03B
| $605K | ﹤0.01% |
31,850
-9,300
| -23% | -$171K |
|
2137
Simulations Plus
SLP
$371M
| $605K | ﹤0.01% |
20,800
-3,400
| -14% | -$115K |
|
2138
Omeros
OMER
$986M
| $604K | ﹤0.01% |
42,900
-6,400
| -13% | -$93.7K |
|
2139
uniQure
QURE
$3.2B
| $604K | ﹤0.01% |
8,425
+2,369
| +39% | +$130K |
|
2140
York Water
YORW
$518M
| $604K | ﹤0.01% |
13,100
| – | – |
|
2141
Pacific Biosciences
PACB
$357M
| $603K | ﹤0.01% |
117,400
-21,500
| -15% | -$109K |
|
2142
National Beverage
FIZZ
$2.91B
| $602K | ﹤0.01% |
23,600
-400
| -2% | -$9.61K |
|
2143
Gossamer Bio
GOSS
$86.1M
| $602K | ﹤0.01% |
38,500
-200
| -0.5% | -$4.03K |
|
2144
Hawthorn Bancshares
HWBK
$275M
| $602K | ﹤0.01% |
27,627
+2,414
| +10% | +$50K |
|
|
CPRX
2145
DELISTED
Catalyst Pharmaceutical
CPRX
| $601K | ﹤0.01% |
160,271
+63,377
| +65% | +$296K |
|
2146
Prothena Corp
PRTA
$468M
| $601K | ﹤0.01% |
37,969
| – | – |
|
|
QADA
2147
DELISTED
QAD Inc.
QADA
| $601K | ﹤0.01% |
11,800
-100
| -0.8% | -$4.78K |
|
|
HUD
2148
DELISTED
Hudson Ltd. Class A Common Shares
HUD
| $598K | ﹤0.01% |
39,000
| – | – |
|
2149
Sterling Infrastructure
STRL
$16.2B
| $597K | ﹤0.01% |
42,415
-18,891
| -31% | -$285K |
|
|
SBT
2150
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
| $597K | ﹤0.01% |
73,700
| – | – |
|
Similar funds
CBU
New York State Common Retirement Fund's Q4 2019 Portfolio in Review
As of Q4 2019, New York State Common Retirement Fund held 3,277 positions worth $84.1B, up 6.4% from $79B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 3.8%. New York State Common Retirement Fund opened 52 new positions and exited 73, leaving the 3,277-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- New York State Common Retirement Fund's largest Q4 2019 buy was Canadian National Railway: 160,800 shares worth $14.5M.
- New York State Common Retirement Fund added most to Bristol-Myers Squibb in Q4 2019, an estimated $86.8M increase.
- New York State Common Retirement Fund's biggest Q4 2019 reduction was Apple, cutting an estimated $55.2M.
- New York State Common Retirement Fund fully exited Celgene Corp in Q4 2019, selling an estimated $159M.
- New York State Common Retirement Fund's ten largest holdings make up 19% of its $84.1B portfolio in Q4 2019.
- New York State Common Retirement Fund opened 52 new positions and closed 73 in Q4 2019.
- New York State Common Retirement Fund's portfolio value rose 6.4% quarter-over-quarter to $84.1B.
Based on New York State Common Retirement Fund's 13F filing for Q4 2019, filed 5 Feb 2020.